Form 8-K - Current report:
SEC Accession No. 0001641172-25-014565
Filing Date
2025-06-10
Accepted
2025-06-10 17:20:53
Documents
12
Period of Report
2025-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44417
  Complete submission text file 0001641172-25-014565.txt   203322

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cqens-20250609.xsd EX-101.SCH 3008
3 XBRL LABEL FILE cqens-20250609_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cqens-20250609_pre.xml EX-101.PRE 22353
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3240
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55470 | Film No.: 251038064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)